GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
-11
c/retatrutide·posted 2 years ago by u/mateusz_mensah

[Discussion] can we stop arguing about triple agonist until somebody posts a number

Discussion

Genuine question, and the title is the question: can we stop arguing about triple agonist until somebody posts a number.

Stopped at a low step because there was no reason to go further and no data to tell me what further would do.

The thing that surprised me was how much of the discussion here is inference rather than measurement.

Kept a log specifically because there is so little published. It is one person and it is not data.

Happy to answer the boring questions. Those are usually the ones worth asking.

99 up / 110 down47% upvoted7 commentsid gstvqv29 Jul 2024

7 comments

7 in this archive, depth 5

best — the order this archive was captured in

u/tired_ledger_notes5 points·2 years ago·edited

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

replysharereportpermalink
u/incretin_ivyMOD4 points·1 year ago

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

replysharereportpermalink
u/mateusz_mensahOP2 points·1 year ago·edited

Is that the 48-week figure or an earlier readout?

replysharereportpermalink
u/hugo_pires1 point·1 year ago

research-use-only material is not approved for human use, full stop

replysharereportpermalink
u/rohan_cardoso1 point·1 year ago

How fast was the escalation? That is usually the variable that explains the reports.

replysharereportpermalink
[removed]1 point·1 year ago

[removed by moderator]

replysharereportpermalink
load more comments (1) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.